Ipilimumab/nivolumab

Colitis and diarrhoea: 11 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Yanai S, et al. Immune checkpoint inhibitor-induced diarrhea: Clinicopathological study of 11 patients. Digestive Endoscopy 32: 616-620, No. 4, May 2020. Available from: URL: http://doi.org/10.1111/den.13555

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ipilimumab/nivolumab. Reactions Weekly 1810, 120 (2020). https://doi.org/10.1007/s40278-020-80140-2

    Download citation